ADH-6 TFA
Based on 1 Customer Validation
ADH-6 TFA is a tripyridylamide compound. ADH-6 abrogates self-assembly of the aggregation-nucleating subdomain of mutant p53 DBD. ADH-6 TFA targets and dissociates mutant p53 aggregates in human cancer cells, which restores p53's transcriptional activity, leading to cell cycle arrest and apoptosis. ADH-6 TFA has the potential for the research of cancer diseases.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Pureté: 99.67%
- CAS No.: 2990065-87-5
- Formule: C31H37F3N8O11
- Masse moléculaire:754.67
-
Stockage:
4°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Activité biologique
-
Chemical Information
-
Solvant et solubilité
- Pureté et documentation
- Références
-
Help & FAQs
-
Apoptosis Compound Library
HY-L003
-
Anti-Cancer Compound Library
HY-L025
-
Autophagy Compound Library
HY-L029
-
Anti-Aging Compound Library
HY-L034
-
Ferroptosis Compound Library
HY-L051
-
Pyroptosis Compound Library
HY-L059
-
Glutamine Metabolism Compound Library
HY-L064
-
Anti-Pancreatic Cancer Compound Library
HY-L077
-
Anti-Blood Cancer Compound Library
HY-L079
-
Anti-Cancer Metabolism Compound Library
HY-L083
-
Transcription Factor-Targeted Library
HY-L090
-
Heterocyclic Compound Library
HY-L138
-
Cell Death Library
HY-L162
-
Anti-Hematopathy Compound Library
HY-L171
-
Bioactive Compound Library Max
HY-L181
-
MCE Bioactive Compound Library
HY-L001V
-
Bioactive Compound Library
HY-L001
-
Non-Alcoholic Fatty Liver Disease (NAFLD) Compound Library
HY-L199
-
Cell Proliferation Compound Library
HY-L201
-
High-Throughput Bioactive Compound Library
HY-L205
Activité biologique
ADH-6 (25 μM, 10 h) TFA inhibits aggregation of pR248W (indicated by dot blot assay)[1].
ADH-6 (5 μM, 6 h) TFA dissociates intracellular mutant p53 aggregates in MIA PaCa-2 cells[1].
ADH-6 (0-10 μM, 24 or 48 h) TFA causes selective cytotoxicity in cancer cells bearing mutant p53 (MIA PaCa-2)[1].
ADH-6 (5 μM, 24 h) TFA specifically targets and reactivates aggregation-prone mutant p53 in MIA PaCa-2 cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:MIA PaCa-2 (mutant R248W p53), SK-BR-3 (mutant R175H p53)
-
Concentration:0, 2.5, 5, 7.5, 10 μM
-
Incubation Time:24, 48 h
-
Result:Caused death of cancer cells bearing mutant, but not WT, p53.
-
Cell Line:MIA PaCa-2 cells
-
Concentration:5 μM
-
Incubation Time:24 h
-
Result:Increased expression of p53-inducible MDM2 and proapoptotic Bax.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:MIA PaCa-2 xenografts[1]
-
Dosage:716.4 µM in 0.02% DMSO
-
Administration:Intraperitoneal injection, every 2 days, for a total of 12 doses
-
Result:Reduced tumor growth relative to the saline-treated control group.
Reduced mutant p53 levels and shrinked xenografts harboring aggregation-prone mutant p53.
-
Animal Model:MIA PaCa-2 xenografts (pharmacokinetics assay)[1]
-
Dosage:15 mg/kg
-
Administration:Intraperitoneal injection, for a single dose
-
Result:Cmax: 21 µg/mL, T1/2: 3.6 h
Chemical Information
-
CAS No. 2990065-87-5
-
Appearance Solid
-
Masse moléculaire 754.67
-
Formule C31H37F3N8O11
-
Color Off-white to light yellow
-
SMILES
O=C(C1=NC(OCCCN)=C(NC(C2=NC(OCCCN)=C(NC(C3=NC(OCCCC)=C([N+]([O-])=O)C=C3)=O)C=C2)=O)C=C1)OC.OC(C(F)(F)F)=O
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
4°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Solvant et solubilité
DMSO : 100 mg/mL (132.51 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Pureté et documentation
-
Fiche technique (275 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Instruction de manipulation (2659 KB)
Références
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 1.3251 mL | 6.6254 mL | 13.2508 mL | 33.1271 mL |
| 5 mM | 0.2650 mL | 1.3251 mL | 2.6502 mL | 6.6254 mL | |
| 10 mM | 0.1325 mL | 0.6625 mL | 1.3251 mL | 3.3127 mL | |
| 15 mM | 0.0883 mL | 0.4417 mL | 0.8834 mL | 2.2085 mL | |
| 20 mM | 0.0663 mL | 0.3313 mL | 0.6625 mL | 1.6564 mL | |
| 25 mM | 0.0530 mL | 0.2650 mL | 0.5300 mL | 1.3251 mL | |
| 30 mM | 0.0442 mL | 0.2208 mL | 0.4417 mL | 1.1042 mL | |
| 40 mM | 0.0331 mL | 0.1656 mL | 0.3313 mL | 0.8282 mL | |
| 50 mM | 0.0265 mL | 0.1325 mL | 0.2650 mL | 0.6625 mL | |
| 60 mM | 0.0221 mL | 0.1104 mL | 0.2208 mL | 0.5521 mL | |
| 80 mM | 0.0166 mL | 0.0828 mL | 0.1656 mL | 0.4141 mL | |
| 100 mM | 0.0133 mL | 0.0663 mL | 0.1325 mL | 0.3313 mL |
ADH-6 TFA Related Classifications
HY-145785A Related Classifications
Powered by Bioz